Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Colitis, Ulcerative 1Arthritis, Rheumatoid 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × golimumab × Clear all
NCT01295151 2016-11-02

SWITCH

University of Leeds

Phase 4 Completed
122 enrolled

Arthritis, Rheumatoid

NCT02186886 2014-07-10

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Kliniken im Naturpark Altmuehltal

Phase 4 Unknown
50 enrolled

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡